Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00289939 · ClinicalTrials.gov registry record · Phase 3
Reducing HIV & Domestic Violence Risk in Women Offenders
A Phase 3 study of HIV Infections and Sexually Transmitted Diseases, sponsored by Multnomah County Health Department.
- Completed
- Registry status
- Phase 3
- Development phase
- 530
- Enrollment target
- 1
- Study location
NCT00289939 is a Phase 3 study of HIV Infections and Sexually Transmitted Diseases that has completed, run by Multnomah County Health Department. The registered enrollment target is 530 participants, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (19% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00289939, a Phase 3 study of HIV Infections and Sexually Transmitted Diseases, has completed, sponsored by Multnomah County Health Department.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 530 participants
- Enrollment target
- 1
- Study location
Study Summary
The long-term goal of this work is to reduce the prevalence of HIV and domestic violence among women at risk by encouraging self-protective behaviors. To obtain this goal, Multnomah County Health Department and Oregon Department of Human Services have conducted a randomized trial of an intervention to prevent HIV and domestic violence among women who have recent criminal justice involvement and who are at risk for HIV infection. Women enrolled in the study were randomly assigned to one of three study conditions: * Group 1: these women received information on local resources addressing HIV prevention, domestic violence, and life stability issues; they did not receive any counseling sessions as part of the study itself. * Group 2: these women received up to ten supportive counseling sessions based on the techniques of motivational interviewing. These sessions aimed to reduce HIV risk and to improve life stability. * Group 3: these women received up to ten supportive counseling sessions based on motivational interviewing. These sessions aimed to reduce risk for HIV and domestic violence and to improve life stability. The primary hypotheses of this study were: * 1\. Supportive counseling (motivational interviewing) addressing HIV prevention and increased life stability will lead to reductions of HIV risk behavior among women enrolled in the study. * 2\. Supportive counseling (motivational interviewing) addressing domestic violence prevention, HIV prevention, and increased life stability, will bring about reductions in experiences of domestic violence and a reduction of HIV risk among these women. * 3\. The supportive counseling received in this study will enhance these women's self-efficacy, self-esteem, and psychological well-being. Women in all three experimental groups were interviewed at the beginning of the study and again after 4, 7, and 10 months. These assessment interviews asked questions about: HIV risk; experiences of domestic violence; and life stabilit
Conditions Studied
Interventions
- BEHAVIORAL Motivational interviewing to reduce risk for HIV and DV
Study Locations (1)
Oregon
- SE Health Center - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 530 participants |
| Start Date | 2000-09 |
| Est. Completion | 2005-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00289939
The ClinicalTrials.gov registry entry for NCT00289939 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 530 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (19% higher). The listed sponsor is Multnomah County Health Department, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Motivational interviewing to reduce risk for HIV and DV is the first listed.
NCT00289939 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT00289939 about?
NCT00289939 is a clinical study titled "Reducing HIV & Domestic Violence Risk in Women Offenders". The long-term goal of this work is to reduce the prevalence of HIV and domestic violence among women at risk by encouraging self-protective behaviors. To obtain this goal, Multnomah County Health Department and Oregon Department of Human Services have conducted a randomized trial of an intervention ...
What is the current status of trial NCT00289939?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 530 participants. The study started on 2000-09. Estimated completion is 2005-01.
What conditions does trial NCT00289939 study?
This clinical trial studies the following conditions: HIV Infections, Sexually Transmitted Diseases, Domestic Violence.
What interventions are being tested in trial NCT00289939?
The interventions under investigation include: Motivational interviewing to reduce risk for HIV and DV (BEHAVIORAL).
Who is sponsoring clinical trial NCT00289939?
This trial is sponsored by Multnomah County Health Department, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00289939 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
RECRUITING · Phase 3
-
Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
RECRUITING · Phase 3
-
SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder
RECRUITING · Phase 3
-
Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
ACTIVE NOT RECRUITING · Phase 3
-
A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF
ACTIVE NOT RECRUITING · Phase 3
-
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
ACTIVE NOT RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.